Therapies in early development for the treatment of urinary tract inflammation

Area of Science:

• Urology
• Infectious Diseases
• Pharmacology

Background:

• Urinary tract inflammation is a prevalent clinical issue often treated with antibiotics.
• Antimicrobial resistance and high recurrence rates in urinary tract infections (UTIs) highlight the need for novel therapeutic strategies.

Purpose of the Study:

• To review emerging management strategies and current research for acute and recurrent urinary tract infections (UTIs).
• To examine a spectrum of novel therapeutics beyond traditional antibiotics for UTI treatment.

Main Methods:

• Literature review of emerging management strategies for UTIs.
• Analysis of current research on novel therapeutics including antibiotics, vaccines, mannosides, hyaluronic acid, probiotics, immunomodulators, and nanotechnology-derived compounds.
• Focus on both acute and recurrent UTI cases.

Main Results:

• Basic science research has advanced the understanding of UTI pathogenesis, paving the way for new therapies.
• Evidence primarily stems from animal models (murine models of bacterial cystitis).

Conclusions:

• Despite progress in understanding UTI pathogenesis, clinical trial data remains limited, hindering robust evidence for new therapies.
• The heterogeneity and virulence of uropathogens present ongoing challenges for scientists and clinicians in developing effective treatments.